AI assistant
Elevance Health, Inc. — Director's Dealing 2021
Mar 3, 2021
29933_dirs_2021-03-03_56c1dc49-8d20-422b-9ee4-0232a6722059.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01
Reporting Person: Gallina John E (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | F | 10633 | $311.48 | Disposed | 28571 | Direct |
| 2021-03-01 | Common Stock | A | 3010 | — | Acquired | 31581 | Direct |
| 2021-03-01 | Common Stock | A | 23222 | — | Acquired | 54803 | Direct |
| 2021-03-02 | Common Stock | F | 483 | $311.66 | Disposed | 54320 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option (Right to Buy) | $311.48 | A | 12357 | Acquired | 2031-03-01 | Common Stock (12357.0) | Direct |
Footnotes
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 1,003 shares each on 3/1/2022 and 3/1/2023, and 1,004 on 3/1/2024.
F3: Represents performance based restricted share units. Restrictions lapse on 3/1/2021.
F4: The option represents a right to purchase a total of 12,357 shares, and is exercisable in three annual installments of 4,119 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.